-
1
-
-
75449099731
-
Medicine's ethical responsibility for health care reform: The Top Five list
-
Brody H,. Medicine's ethical responsibility for health care reform: the Top Five list. N Engl J Med 2010; 362: 283-5.
-
(2010)
N Engl J Med
, vol.362
, pp. 283-285
-
-
Brody, H.1
-
2
-
-
84860485822
-
Choosing wisely: Helping physicians and patients make smart decisions about their care
-
Cassel CK, Guest JA,. Choosing wisely: helping physicians and patients make smart decisions about their care. JAMA 2012; 307: 1801-2.
-
(2012)
JAMA
, vol.307
, pp. 1801-1802
-
-
Cassel, C.K.1
Guest, J.A.2
-
3
-
-
0037022219
-
Medical professionalism in the new millennium: A physician charter
-
ABIM Foundation, American Board of Internal Medicine, ACP-ASIM Foundation, American College of Physicians-American Society of Internal Medicine, European Federation of Internal Medicine
-
ABIM Foundation, American Board of Internal Medicine, ACP-ASIM Foundation, American College of Physicians-American Society of Internal Medicine, European Federation of Internal Medicine. Medical professionalism in the new millennium: a physician charter. Ann Intern Med 2002; 136: 243-6.
-
(2002)
Ann Intern Med
, vol.136
, pp. 243-246
-
-
-
6
-
-
33144490691
-
Grading strength of recommendations and quality of evidence in clinical guidelines: Report from an American College of Chest Physicians task force
-
DOI 10.1378/chest.129.1.174
-
Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force. Chest 2006; 129: 174-81. (Pubitemid 43265259)
-
(2006)
Chest
, vol.129
, Issue.1
, pp. 174-181
-
-
Guyatt, G.1
Gutterman, D.2
Baumann, M.H.3
Addrizzo-Harris, D.4
Hylek, E.M.5
Phillips, B.6
Raskob, G.7
Lewis, S.Z.8
Schunemann, H.9
-
7
-
-
67651229051
-
'Marginal medicine': Targeting comparative effectiveness research to reduce waste
-
Hoffman A, Pearson SD,. 'Marginal medicine': targeting comparative effectiveness research to reduce waste. Health Aff (Millwood) 2009; 28: w710-8.
-
(2009)
Health Aff (Millwood)
, vol.28
-
-
Hoffman, A.1
Pearson, S.D.2
-
8
-
-
0033979858
-
Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens
-
Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA, and the American College of Pathologists. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med 2000; 124: 71-81. (Pubitemid 30053777)
-
(2000)
Archives of Pathology and Laboratory Medicine
, vol.124
, Issue.1
, pp. 71-81
-
-
Kavanaugh, A.1
Tomar, R.2
Reveille, J.3
Solomon, D.H.4
Homburger, H.A.5
-
9
-
-
0037103187
-
Evidence-based guidelines for the use of immunologic tests: Antinuclear antibody testing
-
Solomon DH, Kavanaugh AJ, Schur PH, and the American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 2002; 47: 434-44. (Pubitemid 34856134)
-
(2002)
Arthritis Care and Research
, vol.47
, Issue.4
, pp. 434-444
-
-
Solomon, D.H.1
Kavanaugh, A.J.2
Schur, P.H.3
Solomon, D.H.4
Schur, P.5
Kavanaugh, A.F.6
Reveille, J.D.7
Sherrer, Y.R.S.8
Lahita, R.9
-
10
-
-
0036320108
-
Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases
-
DOI 10.1309/Y5VF-C3DM-L8XV-U053
-
Tozzoli R, Bizzaro N, Tonutti E, Villalta D, Bassetti D, Manoni F, et al. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 2002; 117: 316-24. (Pubitemid 34823674)
-
(2002)
American Journal of Clinical Pathology
, vol.117
, Issue.2
, pp. 316-324
-
-
Tozzoli, R.1
Bizzaro, N.2
Tonutti, E.3
Villalta, D.4
Bassetti, D.5
Manoni, F.6
Piazza, A.7
Pradella, M.8
Rizzotti, P.9
-
11
-
-
84855822380
-
Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious care
-
et al.
-
Qaseem A, Alguire P, Dallas P, Feinberg LE, Fitzgerald FT, Horwitch C, et al. Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious care. Ann Intern Med 2012; 156: 147-9.
-
(2012)
Ann Intern Med
, vol.156
, pp. 147-149
-
-
Qaseem, A.1
Alguire, P.2
Dallas, P.3
Feinberg, L.E.4
Fitzgerald, F.T.5
Horwitch, C.6
-
12
-
-
0035015310
-
Is it useful to test for antibodies to extractable nuclear antigens in the presence of a negative antinuclear antibody on Hep-2 cells? [4]
-
DOI 10.1136/jcp.54.5.413
-
Thomson KF, Murphy A, Goodfield MJ, Misbah SA,. Is it useful to test for antibodies to extractable nuclear antigens in the presence of a negative antinuclear antibody on Hep-2 cells? [letter]. J Clin Pathol 2001; 54: 413. (Pubitemid 32458148)
-
(2001)
Journal of Clinical Pathology
, vol.54
, Issue.5
, pp. 413
-
-
Thomson, K.F.1
Murphy, A.2
Goodfield, M.J.D.3
Misbah, S.A.4
-
14
-
-
0029949454
-
Antinuclear antibody testing: A study of clinical utility
-
DOI 10.1001/archinte.156.13.1421
-
Slater CA, Davis RB, Shmerling RH,. Antinuclear antibody testing: a study of clinical utility. Arch Intern Med 1996; 156: 1421-5. (Pubitemid 26226936)
-
(1996)
Archives of Internal Medicine
, vol.156
, Issue.13
, pp. 1421-1425
-
-
Slater, C.A.1
Davis, R.B.2
Shmerling, R.H.3
-
15
-
-
0022073529
-
A negative fluorescent antinuclear antibody test in a patient with Jo-1 antibody
-
Bahrt KM, McCarty GA,. A negative fluorescent antinuclear antibody test in a patient with Jo-1 antibody. J Rheumatol 1985; 12: 624-5.
-
(1985)
J Rheumatol
, vol.12
, pp. 624-625
-
-
Bahrt, K.M.1
McCarty, G.A.2
-
16
-
-
0036892180
-
Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests
-
Hoffman IE, Peene I, Veys EM, De Keyser F,. Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests. Clin Chem 2002; 48: 2171-6. (Pubitemid 35397559)
-
(2002)
Clinical Chemistry
, vol.48
, Issue.12
, pp. 2171-2176
-
-
Hoffman, I.E.A.1
Peene, I.2
Veys, E.M.3
De Keyser, F.4
-
17
-
-
1642399760
-
Methods of choice for diagnostic antinuclear antibody (ANA) screening: Benefit of adding antigen-specific assays to immunofluorescence microscopy
-
DOI 10.1016/j.jaut.2003.12.004, PII S089684110300194X
-
Dahle C, Skogh T, Aberg AK, Jalal A, Olcen P,. Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy. J Autoimmun 2004; 22: 241-8. (Pubitemid 38369185)
-
(2004)
Journal of Autoimmunity
, vol.22
, Issue.3
, pp. 241-248
-
-
Dahle, C.1
Skogh, T.2
Aberg, A.K.3
Jalal, A.4
Olcen, P.5
-
18
-
-
28044462897
-
Antibodies to extractable nuclear antigens in antinuclear antibody-negative samples [6]
-
DOI 10.1373/clinchem.2005.058552
-
Bossuyt X, Luyckx A,. Antibodies to extractable nuclear antigens in antinuclear antibody-negative samples [letter]. Clin Chem 2005; 51: 2426-7. (Pubitemid 41692609)
-
(2005)
Clinical Chemistry
, vol.51
, Issue.12
, pp. 2426-2427
-
-
Bossuyt, X.1
Luyckx, A.2
-
20
-
-
84874505606
-
-
Centers for Disease Control and Prevention
-
Centers for Disease Control and Prevention. Lyme disease diagnosis and treatment. 2011. URL: www.cdc.gov/lyme/diagnosistreatment/index.html.
-
(2011)
Lyme Disease Diagnosis and Treatment
-
-
-
21
-
-
0031439003
-
Guidelines for laboratory evaluation in the diagnosis of Lyme disease
-
American College of Physicians
-
American College of Physicians. Guidelines for laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med 1997; 127: 1106-8.
-
(1997)
Ann Intern Med
, vol.127
, pp. 1106-1108
-
-
-
22
-
-
84864812174
-
Lyme disease
-
Hu LT,. Lyme disease. Ann Intern Med 2012; 157: ITC2-1.
-
(2012)
Ann Intern Med
, vol.157
-
-
Hu, L.T.1
-
23
-
-
33750132121
-
The clinical assessments treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America
-
DOI 10.1086/508667
-
Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006; 43: 1089-134. (Pubitemid 44637131)
-
(2006)
Clinical Infectious Diseases
, vol.43
, Issue.9
, pp. 1089-1134
-
-
Wormser, G.P.1
Dattwyler, R.J.2
Shapiro, E.D.3
Halperin, J.J.4
Steere, A.C.5
Klempner, M.S.6
Krause, P.J.7
Bakken, J.S.8
Strle, F.9
Stanek, G.10
Bockenstedt, L.11
Fish, D.12
Dumler, J.S.13
Nadelman, R.B.14
-
24
-
-
0032554140
-
Tick bites and lyme disease in an endemic: Setting problematic use of serologic testing and prophylactic antibiotic therapy
-
DOI 10.1001/jama.279.3.206
-
Fix AD, Strickland GT, Grant J,. Tick bites and Lyme disease in an endemic setting: problematic use of serologic testing and prophylactic antibiotic therapy. JAMA 1998; 279: 206-10. (Pubitemid 28133782)
-
(1998)
Journal of the American Medical Association
, vol.279
, Issue.3
, pp. 206-210
-
-
Fix, A.D.1
Strickland, G.T.2
Grant, J.3
-
25
-
-
0036632241
-
Lyme disease knowledge, beliefs, and practices of New Hampshire primary care physicians
-
Magri JM, Johnson MT, Herring TA, Greenblatt JF,. Lyme disease knowledge, beliefs, and practices of New Hampshire primary care physicians. J Am Board Fam Pract 2002; 15: 277-84. (Pubitemid 36527745)
-
(2002)
Journal of the American Board of Family Practice
, vol.15
, Issue.4
, pp. 277-284
-
-
Magri, J.M.1
Johnson, M.T.2
Herring, T.A.3
Greenblatt, J.F.4
-
26
-
-
0036144384
-
Overdiagnosis and overtreatment of Lyme disease in children
-
DOI 10.1097/00006454-200201000-00003
-
Qureshi MZ, New D, Zulqarni NJ, Nachman S,. Overdiagnosis and overtreatment of Lyme disease in children. Pediatr Infect Dis J 2002; 21: 12-4. (Pubitemid 34073951)
-
(2002)
Pediatric Infectious Disease Journal
, vol.21
, Issue.1
, pp. 12-14
-
-
Qureshi, M.Z.1
New, D.2
Zulqarni, N.J.3
Nachman, S.4
-
27
-
-
4243088182
-
Appropriateness of lyme disease serologic testing
-
DOI 10.1370/afm.117
-
Ramsey AH, Belongia EA, Chyou PH, Davis JP,. Appropriateness of Lyme disease serologic testing. Ann Fam Med 2004; 2: 341-4. (Pubitemid 39107891)
-
(2004)
Annals of Family Medicine
, vol.2
, Issue.4
, pp. 341-344
-
-
Ramsey, A.H.1
Belongia, E.A.2
Chyou, P.-H.3
Davis, J.P.4
-
28
-
-
0028009435
-
The use of serologic tests for Lyme disease in a prepaid health plan in California
-
DOI 10.1001/jama.271.6.460
-
Ley C, Le C, Olshen EM, Reingold AL,. The use of serologic tests for Lyme disease in a prepaid health plan in California. JAMA 1994; 271: 460-3. (Pubitemid 24043877)
-
(1994)
Journal of the American Medical Association
, vol.271
, Issue.6
, pp. 460-463
-
-
Ley, C.1
Le, C.2
Olshen, E.M.3
Reingold, A.L.4
-
29
-
-
0032030801
-
The consequences of overdiagnosis and overtreatment of Lyme disease: An observational study
-
Reid MC, Schoen RT, Evans J, Rosenberg JC, Horwitz RI,. The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study. Ann Intern Med 1998; 128: 354-62. (Pubitemid 28103103)
-
(1998)
Annals of Internal Medicine
, vol.128
, Issue.5
, pp. 354-362
-
-
Reid, M.C.1
Schoen, R.T.2
Evans, J.3
Rosenberg, J.C.4
Horwitz, R.I.5
-
30
-
-
0031027867
-
Diagnosis and treatment of lyme arthritis
-
DOI 10.1016/S0025-7125(05)70510-1
-
Steere AC,. Diagnosis and treatment of Lyme arthritis. Med Clin North Am 1997; 81: 179-94. (Pubitemid 27043800)
-
(1997)
Medical Clinics of North America
, vol.81
, Issue.1
, pp. 179-194
-
-
Steere, A.C.1
-
31
-
-
84859832981
-
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
-
et al.
-
Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012; 64: 625-39.
-
(2012)
Arthritis Care Res (Hoboken)
, vol.64
, pp. 625-639
-
-
Singh, J.A.1
Furst, D.E.2
Bharat, A.3
Curtis, J.R.4
Kavanaugh, A.F.5
Kremer, J.M.6
-
32
-
-
33846001961
-
EULAR recommendations for the management of early arthritis: Report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
-
DOI 10.1136/ard.2005.044354
-
Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M, et al. EULAR recommendations for the management of early arthritis: report of a Task Force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007; 66: 34-45. (Pubitemid 46044858)
-
(2007)
Annals of the Rheumatic Diseases
, vol.66
, Issue.1
, pp. 34-45
-
-
Combe, B.1
Landewe, R.2
Lukas, C.3
Bolosiu, H.D.4
Breedveld, F.5
Dougados, M.6
Emery, P.7
Ferraccioli, G.8
Hazes, J.M.W.9
Klareskog, L.10
Machold, K.11
Martin-Mola, E.12
Nielsen, H.13
Silman, A.14
Smolen, J.15
Yazici, H.16
-
33
-
-
33646434237
-
Extremity magnetic resonance imaging in rheumatoid arthritis: Report of the American College of Rheumatology Extremity Magnetic Resonance Imaging Task Force
-
American College of Rheumatology Extremity Magnetic Resonance Imaging Task Force
-
American College of Rheumatology Extremity Magnetic Resonance Imaging Task Force. Extremity magnetic resonance imaging in rheumatoid arthritis: report of the American College of Rheumatology Extremity Magnetic Resonance Imaging Task Force. Arthritis Rheum 2006; 54: 1034-47.
-
(2006)
Arthritis Rheum
, vol.54
, pp. 1034-1047
-
-
-
34
-
-
79952379852
-
The value of magnetic resonance imaging and ultrasound in undifferentiated arthritis: A systematic review
-
Machado PM, Koevoets R, Bombardier C, van der Heijde DM,. The value of magnetic resonance imaging and ultrasound in undifferentiated arthritis: a systematic review. J Rheumatol Suppl 2011; 87: 31-7.
-
(2011)
J Rheumatol
, vol.87
, Issue.SUPPL.
, pp. 31-37
-
-
MacHado, P.M.1
Koevoets, R.2
Bombardier, C.3
Van Der Heijde, D.M.4
-
35
-
-
84856548590
-
Magnetic resonance imaging in psoriatic arthritis: Update on current status and future perspectives: A report from the GRAPPA 2010 annual meeting
-
Ostergaard M, Poggenborg RP,. Magnetic resonance imaging in psoriatic arthritis: update on current status and future perspectives: a report from the GRAPPA 2010 annual meeting. J Rheumatol 2012; 39: 408-12.
-
(2012)
J Rheumatol
, vol.39
, pp. 408-412
-
-
Ostergaard, M.1
Poggenborg, R.P.2
-
36
-
-
0012973175
-
OMERACT rheumatoid arthritis magnetic resonance imaging studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system
-
Ostergaard M, Peterfy C, Conaghan P, McQueen F, Bird P, Ejbjerg B, et al. OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies: core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. J Rheumatol 2003; 30: 1385-6. (Pubitemid 36666373)
-
(2003)
Journal of Rheumatology
, vol.30
, Issue.6
, pp. 1385-1386
-
-
Ostergaard, M.1
Peterfy, C.2
Conaghan, P.3
McQueen, F.4
Bird, P.5
Ejbjerg, B.6
Shnier, R.7
O'Connor, P.8
Klarlund, M.9
Emery, P.10
Genant, H.11
Lassere, M.12
Edmonds, J.13
-
37
-
-
79958785924
-
Role of magnetic resonance imaging in the diagnosis and prognosis of rheumatoid arthritis
-
Suter LG, Fraenkel L, Braithwaite RS,. Role of magnetic resonance imaging in the diagnosis and prognosis of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2011; 63: 675-88.
-
(2011)
Arthritis Care Res (Hoboken)
, vol.63
, pp. 675-688
-
-
Suter, L.G.1
Fraenkel, L.2
Braithwaite, R.S.3
-
38
-
-
79955069103
-
Cost-effectiveness of adding magnetic resonance imaging to rheumatoid arthritis management
-
Suter LG, Fraenkel L, Braithwaite RS,. Cost-effectiveness of adding magnetic resonance imaging to rheumatoid arthritis management. Arch Intern Med 2011; 171: 657-67.
-
(2011)
Arch Intern Med
, vol.171
, pp. 657-667
-
-
Suter, L.G.1
Fraenkel, L.2
Braithwaite, R.S.3
-
39
-
-
77953696525
-
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
-
et al.
-
Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010; 69: 964-75.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 964-975
-
-
Smolen, J.S.1
Landewe, R.2
Breedveld, F.C.3
Dougados, M.4
Emery, P.5
Gaujoux-Viala, C.6
-
40
-
-
79953041295
-
Treatment of early rheumatoid arthritis: Concepts in management
-
Haraoui B, Pope J,. Treatment of early rheumatoid arthritis: concepts in management. Semin Arthritis Rheum 2011; 40: 371-88.
-
(2011)
Semin Arthritis Rheum
, vol.40
, pp. 371-388
-
-
Haraoui, B.1
Pope, J.2
-
41
-
-
79952219360
-
Cost-effectiveness of biologic response modifiers compared to disease-modifying antirheumatic drugs for rheumatoid arthritis: A systematic review
-
et al. [review]
-
Van der Velde G, Pham B, Machado M, Ieraci L, Witteman W, Bombardier C, et al. Cost-effectiveness of biologic response modifiers compared to disease-modifying antirheumatic drugs for rheumatoid arthritis: a systematic review [review]. Arthritis Care Res (Hoboken) 2011; 63: 65-78.
-
(2011)
Arthritis Care Res (Hoboken)
, vol.63
, pp. 65-78
-
-
Van Der Velde, G.1
Pham, B.2
MacHado, M.3
Ieraci, L.4
Witteman, W.5
Bombardier, C.6
-
42
-
-
77950357873
-
Cost-effectiveness of biologics in early rheumatoid arthritis
-
[letter]
-
Finckh A, Bansback N, Liang MH,. Cost-effectiveness of biologics in early rheumatoid arthritis [letter]. Ann Intern Med 2010; 152: 333-4.
-
(2010)
Ann Intern Med
, vol.152
, pp. 333-334
-
-
Finckh, A.1
Bansback, N.2
Liang, M.H.3
-
43
-
-
79951581065
-
American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis
-
et al.
-
Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W, et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken) 2010; 62: 1515-26.
-
(2010)
Arthritis Care Res (Hoboken)
, vol.62
, pp. 1515-1526
-
-
Grossman, J.M.1
Gordon, R.2
Ranganath, V.K.3
Deal, C.4
Caplan, L.5
Chen, W.6
-
44
-
-
77954254610
-
-
National Osteoporosis Foundation. Washington, DC: National Osteoporosis Foundation
-
National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation; 2010. p. 1-36.
-
(2010)
Clinician's Guide to Prevention and Treatment of Osteoporosis
, pp. 1-36
-
-
-
45
-
-
79952230364
-
Screening for osteoporosis: US Preventive Services Task Force recommendation statement
-
US Preventive Services Task Force
-
US Preventive Services Task Force. Screening for osteoporosis: US Preventive Services Task Force recommendation statement. Ann Intern Med 2011; 154: 356-64.
-
(2011)
Ann Intern Med
, vol.154
, pp. 356-364
-
-
-
46
-
-
46249101901
-
Longitudinal trends in use of bone mass measurement among older Americans, 1999-2005
-
DOI 10.1359/jbmr.080232
-
Curtis JR, Carbone L, Cheng H, Hayes B, Laster A, Matthews R, et al. Longitudinal trends in use of bone mass measurement among older Americans, 1999-2005. J Bone Miner Res 2008; 23: 1061-7. (Pubitemid 351915728)
-
(2008)
Journal of Bone and Mineral Research
, vol.23
, Issue.7
, pp. 1061-1067
-
-
Curtis, J.R.1
Carbone, L.2
Cheng, H.3
Hayes, B.4
Laster, A.5
Matthews, R.6
Saag, K.G.7
Sepanski, R.8
Tanner, S.B.9
Delzell, E.10
-
47
-
-
84855666535
-
Medicare payment cuts for osteoporosis testing reduced use despite tests' benefit in reducing fractures
-
King AB, Fiorentino DM,. Medicare payment cuts for osteoporosis testing reduced use despite tests' benefit in reducing fractures. Health Aff (Millwood) 2011; 30: 2362-70.
-
(2011)
Health Aff (Millwood)
, vol.30
, pp. 2362-2370
-
-
King, A.B.1
Fiorentino, D.M.2
-
48
-
-
77954288455
-
Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: Application of the systemic lupus erythematosus quality indicators
-
Schmajuk G, Yelin E, Chakravarty E, Nelson LM, Panopolis P, Yazdany J,. Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators. Arthritis Care Res (Hoboken) 2010; 62: 993-1001.
-
(2010)
Arthritis Care Res (Hoboken)
, vol.62
, pp. 993-1001
-
-
Schmajuk, G.1
Yelin, E.2
Chakravarty, E.3
Nelson, L.M.4
Panopolis, P.5
Yazdany, J.6
-
49
-
-
0034092979
-
Prediction of fracture from low bone mineral density measurements overestimates risk
-
DOI 10.1016/S8756-3282(00)00238-6, PII S8756328200002386
-
Kanis JA, Johnell O, Oden A, Jonsson B, De Laet C, Dawson A,. Prediction of fracture from low bone mineral density measurements overestimates risk. Bone 2000; 26: 387-91. (Pubitemid 30136130)
-
(2000)
Bone
, vol.26
, Issue.4
, pp. 387-391
-
-
Kanis, J.A.1
Johnell, O.2
Oden, A.3
Jonsson, B.4
De Laet, C.5
Dawson, A.6
-
50
-
-
33846455421
-
Evaluating the value of repeat bone mineral density measurement and prediction of fractures in older women: The study of osteoporotic fractures
-
DOI 10.1001/archinte.167.2.155
-
Hillier TA, Stone KL, Bauer DC, Rizzo JH, Pedula KL, Cauley JA, et al. Evaluating the value of repeat bone mineral density measurement and prediction of fractures in older women: the study of osteoporotic fractures. Arch Intern Med 2007; 167: 155-60. (Pubitemid 46148062)
-
(2007)
Archives of Internal Medicine
, vol.167
, Issue.2
, pp. 155-160
-
-
Hillier, T.A.1
Stone, K.L.2
Bauer, D.C.3
Rizzo, J.H.4
Pedula, K.L.5
Cauley, J.A.6
Ensrud, K.E.7
Hochberg, M.C.8
Cummings, S.R.9
-
51
-
-
84863347003
-
Central DXA utilization shifts from office-based to hospital-based settings among Medicare beneficiaries in the wake of reimbursement changes
-
et al.
-
Zhang J, Delzell E, Zhao H, Laster AJ, Saag KG, Kilgore ML, et al. Central DXA utilization shifts from office-based to hospital-based settings among Medicare beneficiaries in the wake of reimbursement changes. J Bone Miner Res 2012; 27: 858-64.
-
(2012)
J Bone Miner Res
, vol.27
, pp. 858-864
-
-
Zhang, J.1
Delzell, E.2
Zhao, H.3
Laster, A.J.4
Saag, K.G.5
Kilgore, M.L.6
-
52
-
-
84862908900
-
Bone-density testing interval and transition to osteoporosis in older women
-
et al.
-
Gourlay ML, Fine JP, Preisser JS, May RC, Li C, Lui LY, et al. Bone-density testing interval and transition to osteoporosis in older women. N Engl J Med 2012; 366: 225-33.
-
(2012)
N Engl J Med
, vol.366
, pp. 225-233
-
-
Gourlay, M.L.1
Fine, J.P.2
Preisser, J.S.3
May, R.C.4
Li, C.5
Lui, L.Y.6
-
53
-
-
28144450564
-
Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: Reduction in risk of nonvertebral fracture is not related to change in BMD
-
DOI 10.1359/JBMR.050814
-
Watts NB, Geusens P, Barton IP, Felsenberg D,. Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD. J Bone Miner Res 2005; 20: 2097-104. (Pubitemid 41698773)
-
(2005)
Journal of Bone and Mineral Research
, vol.20
, Issue.12
, pp. 2097-2104
-
-
Watts, N.B.1
Geusens, P.2
Barton, I.P.3
Felsenberg, D.4
-
54
-
-
0037125875
-
Screening for postmenopausal osteoporosis: A review of the evidence for the U.S. Preventive Services Task Force
-
Nelson HD, Helfand M, Woolf SH, Allan JD,. Screening for postmenopausal osteoporosis: a review of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002; 137: 529-41. (Pubitemid 35024625)
-
(2002)
Annals of Internal Medicine
, vol.137
, Issue.6
, pp. 529-541
-
-
Nelson, H.D.1
Helfand, M.2
Woolf, S.H.3
Allan, J.D.4
-
55
-
-
0036133350
-
Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy
-
Sarkar S, Mitlak BH, Wong M, Stock JL, Black DM, Harper KD,. Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy. J Bone Miner Res 2002; 17: 1-10. (Pubitemid 33150990)
-
(2002)
Journal of Bone and Mineral Research
, vol.17
, Issue.1
, pp. 1-10
-
-
Sarkar, S.1
Mitlak, B.H.2
Wong, M.3
Stock, J.L.4
Black, D.M.5
Harper, K.D.6
-
56
-
-
13144306555
-
Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: The fracture intervention trial
-
DOI 10.1359/JBMR.040512
-
Bauer DC, Black DM, Garnero P, Hochberg M, Ott S, Orloff J, et al. Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial. J Bone Miner Res 2004; 19: 1250-8. (Pubitemid 41094365)
-
(2004)
Journal of Bone and Mineral Research
, vol.19
, Issue.8
, pp. 1250-1258
-
-
Bauer, D.C.1
Black, D.M.2
Garnero, P.3
Hochberg, M.4
Ott, S.5
Orloff, J.6
Thompson, D.E.7
Ewing, S.K.8
Delmas, P.D.9
|